TRDA - Entrada Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TRDA is currently covered by 3 analysts with an average price target of $15.24. This is a potential upside of $7.11 (87.45%) from yesterday's end of day stock price of $8.13.

Entrada Therapeutics's activity chart (see below) currently has 1 price targets and 17 ratings on display. The stock rating distribution of TRDA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 34.62% with an average time for these price targets to be met of 45.5 days.

Highest price target for TRDA is $28, Lowest price target is $20, average price target is $25.33.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 31-Mar-2025. First documented stock forecast 23-Nov-2021.

Best performing analysts who are covering TRDA - Entrada Therapeutics:

Raghuram Selvaraju Chris Shibutani Francois Brisebois Hartaj Singh

Currently out of the existing stock ratings of TRDA, 16 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$20

$11.87 (146.00%)

$20

20 days ago
(31-Mar-2025)

5/13 (38.46%)

$10.96 (121.24%)

175

Buy

$28

$19.87 (244.40%)

$25

5 months 14 days ago
(06-Nov-2024)

0/2 (0%)

$9.34 (50.05%)

Buy

$28

$19.87 (244.40%)

$22

5 months 14 days ago
(06-Nov-2024)

0/2 (0%)

$9.34 (50.05%)

Hold

$18

$4.56 (33.93%)

$13

2 years 5 months 12 days ago
(08-Nov-2022)

3/3 (100%)

$-1.2 (-6.25%)

7

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TRDA (Entrada Therapeutics) average time for price targets to be met?

On average it took 45.5 days on average for the stock forecasts to be realized with a an average price target met ratio 34.62

Which analyst has the current highest performing score on TRDA (Entrada Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on TRDA (Entrada Therapeutics) with a proven track record?

HARTAJ SINGH

Which analyst has the most public recommendations on TRDA (Entrada Therapeutics)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 3 price targets and 16 ratings on TRDA

Which analyst is the currently most bullish on TRDA (Entrada Therapeutics)?

Hartaj Singh with highest potential upside - $19.87

Which analyst is the currently most reserved on TRDA (Entrada Therapeutics)?

Chris Shibutani with lowest potential downside - $4.56

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?